|
Clinical Relevance
First level information About Clinical Relevance & List of Abbreviations |
|
▶ The AC-29 pattern is highly specific for systemic sclerosis (SSc), in particular with diffuse cutaneous SSc and more aggressive forms of SSc [1-3]. ▶ If SSc is clinically suspected, it is recommended to perform a follow-up test for anti-Topoisomerase I; these antibodies are included in the classification criteria for SSc and the antigen is included in routine ENA profiles [3-5]. |
| First level information references |
|
|
| Second level information |
|
None |
| Second level information references |
|
1. Andrade LEC, Klotz W, Herold M, Conrad K, Ronnelid J, Fritzler MJ, von Muhlen CA, Satoh M, et al. International consensus on antinuclear antibody patterns: definition of the AC-29 pattern associated with antibodies to DNA topoisomerase I. Clin Chem Lab Med. 2018;56:1783-8. 2. Dellavance A, Gallindo C, Soares MG, da Silva NP, Mortara RA, Andrade LE. Redefining the Scl-70 indirect immunofluorescence pattern: autoantibodies to DNA topoisomerase I yield a specific compound immunofluorescence pattern. Rheumatology (Oxford). 2009;48:632-7. 3. Johnson SR, Fransen J, Khanna D, Baron M, van den Hoogen F, Medsger TA, Jr., Peschken CA, Carreira PE, et al. Validation of potential classification criteria for systemic sclerosis. Arthritis Care Res. 2012;64:358-67. 4. van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013;72:1747-55. 5. Basu D, Reveille JD. Anti-scl-70. Autoimmunity. 2005;38:65-72. |
| FAQ |
|
Fine Art with AC-29. Is it critical that all five elements of the subcellular domains associated with the AC-29 pattern be evaluated in order to correctly classify an individual serum as AC-29? In other words, can it be classified as AC-29 with staining of only some of the five elements? |